SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics (NASDAQ:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by applying our unique capabilities for targeting the liver and liver pathways, announced today that Dr. Paul Laikind, chairman, president and chief executive officer of Metabasis will present at the Jefferies Healthcare Conference in New York, NY. Dr. Laikind is scheduled to present on Wednesday, June 27, 2007 at 2:40 p.m. Eastern Time, and is expected to provide an overview of the Company’s progress and discuss product candidates in clinical development.
